Delaware Health News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware Health News Online.

Press releases published on June 30, 2026

Jun. 30, 2026

BellaSeno’s regenerative scaffolds signal new era for breast surgery

Indeterminate GlobeNewswire

Jun. 30, 2026

HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter

Indeterminate GlobeNewswire

Jun. 30, 2026

Candel Therapeutics Announces Initiation of Global Pivotal Phase 3 AURORA Trial Evaluating Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors

Indeterminate GlobeNewswire

Jun. 30, 2026

FEATOL Rolls Out Reinforced Lower Back Brace to Help Adults During Work, Driving, and in Chronic Pain

Indeterminate GlobeNewswire

Jun. 30, 2026

Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses

Indeterminate GlobeNewswire

Jun. 30, 2026

Biodexa Announces Pricing of $3.5 Million Registered Direct Offering & Concurrent Private Placement of Pre-Funded Warrants and Warrants

Indeterminate GlobeNewswire

Jun. 30, 2026

LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations

Indeterminate GlobeNewswire

Jun. 30, 2026

Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic

Indeterminate GlobeNewswire

Jun. 30, 2026

MediciNova CEO Provides Shareholder Update

Indeterminate GlobeNewswire

Jun. 30, 2026

SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Indeterminate GlobeNewswire

Jun. 30, 2026

ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel

Indeterminate GlobeNewswire

Jun. 30, 2026

Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board

Indeterminate GlobeNewswire

Jun. 30, 2026

Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer

Indeterminate GlobeNewswire

Jun. 30, 2026

Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program

Indeterminate GlobeNewswire

Jun. 30, 2026

Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officer

Indeterminate GlobeNewswire

Jun. 30, 2026

Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)

Indeterminate GlobeNewswire

Jun. 30, 2026

Provectus Biopharmaceuticals and VisiRose Announce U.S. Patent Award for Light-Independent Antibacterial Eye Drop Targeting Drug-Resistant Ocular Infections

Indeterminate GlobeNewswire

Jun. 30, 2026

Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease

Indeterminate GlobeNewswire

Jun. 30, 2026

Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1

Indeterminate GlobeNewswire

Jun. 30, 2026

U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA

Indeterminate GlobeNewswire